Page last updated: 2024-11-04

sotalol and Ventricular Dysfunction

sotalol has been researched along with Ventricular Dysfunction in 3 studies

Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

Ventricular Dysfunction: A condition in which HEART VENTRICLES exhibit impaired function.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Couderc, JP1
Kaab, S1
Hinterseer, M1
McNitt, S1
Xia, X1
Fossa, A1
Beckmann, BM1
Polonsky, S1
Zareba, W1
Olesin, AI1
Shabrov, AV1
Sinenko, VI1
Popik, GS1
Boldueva, SA1
Leonova, IA1
Poloskina, OA1
Delacrétaz, E1
Fuhrer, J1

Trials

1 trial available for sotalol and Ventricular Dysfunction

ArticleYear
Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Journal of clinical pharmacology, 2009, Volume: 49, Issue:1

    Topics: Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Male; Middle Aged; Sotalol; Torsades de

2009

Other Studies

2 other studies available for sotalol and Ventricular Dysfunction

ArticleYear
[Possibility of differentiated treatment of ventricular heart rate disturbances based on mechanism of their development].
    Kardiologiia, 2005, Volume: 45, Issue:5

    Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Sotalol; Ventricular Dysfunction

2005
Fatal torsade de pointes with d,l-sotalol and low potassium.
    Clinical cardiology, 1999, Volume: 22, Issue:6

    Topics: Aged; Anti-Arrhythmia Agents; Antihypertensive Agents; Electrocardiography; Fatal Outcome; Female; H

1999